Results 131 to 140 of about 232,611 (270)
Addressing the Clinical Workforce Shortage by Retaining the Tenured Laboratory Professionals. [PDF]
Chiou PZ, Mulder L.
europepmc +1 more source
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas +18 more
wiley +1 more source
The health workforce status in the WHO African Region: findings of a cross-sectional study
Jennifer Nyoni +4 more
doaj +1 more source
Will 'Support at Home' Deliver What Older People Want? [PDF]
Laragy C, McVilly K.
europepmc +1 more source
ABSTRACT Background Neurodegeneration with brain iron accumulation (NBIA) comprises a genetically and clinically heterogeneous group of rare neurological disorders characterized particularly by iron accumulation in the basal ganglia. To date, 15 genes have been associated with NBIA.
Seda Susgun +95 more
wiley +1 more source
Optimizing the contributions of nursing and midwifery workforces: #Protect, #Invest, #Together
James Buchan +2 more
doaj +1 more source
Nursing shortages and migration: a two-decade study of Ireland's dependence on migrant nurses. [PDF]
Chima CO, Renjith V, Humphries N.
europepmc +1 more source
<p>Exploring future health workforce educational needs: a qualitative investigation</p>
Sharon Mickan +2 more
openalex +2 more sources
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source

